CP 3647
References are available as supplementary material at European Heart Journal online
Title: European Commissioners petitioned for clean air and reduced noise pollution
References:
(1) European Cardiovascular Disease Statistics 2012
(2) ESC position paper on air pollution and cardiovascular disease
(3) Munzel T, et al. Environmental hazards, air pollution, and noise as novel cardiovascular
risk factors Eur Heart J (2015) 36(28): 1777-1779
(4) British Heart Foundation. Policy Statement on Air Pollution
(5) Gold DR, et al. Air Pollution, Climate and Heart Disease
(6) SOER 2015 — The European environment — state and outlook 2015
(7) online petition: https://www.change.org/p/environment-and-the-heart
If you need more information on the references write to:
Katell LEMAITRE klemaitre@escardio.org
Title: Should we screen cardiovascular patients for thyroid dysfunction?
References
1.
Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012;379:1142-1154
2.
Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F,
Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F, et al. The incidence of thyroid
disorders in the community: A twenty-year follow-up of the whickham survey.
Clinical endocrinology. 1995;43:55-68
3.
Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO,
Iervasi G, Imaizumi M, Collet TH, Bremner A, Maisonneuve P, Sgarbi JA, Khaw KT,
Vanderpump MP, Newman AB, Cornuz J, Franklyn JA, Westendorp RG, Vittinghoff
E, Gussekloo J. Subclinical hypothyroidism and the risk of coronary heart disease and
mortality. Jama. 2010;304:1365-1374
4.
Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P, Iervasi G,
Asvold BO, Sgarbi JA, Volzke H, Gencer B, Maciel RM, Molinaro S, Bremner A,
Luben RN, Maisonneuve P, Cornuz J, Newman AB, Khaw KT, Westendorp RG,
Franklyn JA, Vittinghoff E, Walsh JP, Rodondi N. Subclinical hyperthyroidism and
the risk of coronary heart disease and mortality. Archives of internal medicine.
2012;172:799-809
5.
Gencer B, Collet TH, Virgini V, Bauer DC, Gussekloo J, Cappola AR, Nanchen D,
den Elzen WP, Balmer P, Luben RN, Iacoviello M, Triggiani V, Cornuz J, Newman
AB, Khaw KT, Jukema JW, Westendorp RG, Vittinghoff E, Aujesky D, Rodondi N.
Subclinical thyroid dysfunction and the risk of heart failure events: An individual
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
participant data analysis from 6 prospective cohorts. Circulation. 2012;126:10401049
Blum MR, Bauer DC, Collet TH, Fink HA, Cappola AR, da Costa BR, Wirth CD,
Peeters RP, Asvold BO, den Elzen WP, Luben RN, Imaizumi M, Bremner AP,
Gogakos A, Eastell R, Kearney PM, Strotmeyer ES, Wallace ER, Hoff M, Ceresini G,
Rivadeneira F, Uitterlinden AG, Stott DJ, Westendorp RG, Khaw KT, Langhammer
A, Ferrucci L, Gussekloo J, Williams GR, Walsh JP, Juni P, Aujesky D, Rodondi N.
Subclinical thyroid dysfunction and fracture risk: A meta-analysis. Jama.
2015;313:2055-2065
Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J, Rodondi N. Metaanalysis: Subclinical thyroid dysfunction and the risk for coronary heart disease and
mortality. Annals of internal medicine. 2008;148:832-845
Simmonds MC, Higgins JP, Stewart LA, Tierney JF, Clarke MJ, Thompson SG.
Meta-analysis of individual patient data from randomized trials: A review of methods
used in practice. Clin Trials. 2005;2:209-217
Rodondi N, Bauer DC, Cappola AR, Cornuz J, Robbins J, Fried LP, Ladenson PW,
Vittinghoff E, Gottdiener JS, Newman AB. Subclinical thyroid dysfunction, cardiac
function, and the risk of heart failure. The cardiovascular health study. Journal of the
American College of Cardiology. 2008;52:1152-1159
Biondi B, Fazio S, Palmieri EA, Carella C, Panza N, Cittadini A, Bone F, Lombardi
G, Sacca L. Left ventricular diastolic dysfunction in patients with subclinical
hypothyroidism. The Journal of clinical endocrinology and metabolism.
1999;84:2064-2067
Ripoli A, Pingitore A, Favilli B, Bottoni A, Turchi S, Osman NF, De Marchi D,
Lombardi M, L'Abbate A, Iervasi G. Does subclinical hypothyroidism affect cardiac
pump performance? Evidence from a magnetic resonance imaging study. Journal of
the American College of Cardiology. 2005;45:439-445
Forfar JC, Wathen CG, Todd WT, Bell GM, Hannan WJ, Muir AL, Toft AD. Left
ventricular performance in subclinical hypothyroidism. The Quarterly journal of
medicine. 1985;57:857-865
Monzani F, Di Bello V, Caraccio N, Bertini A, Giorgi D, Giusti C, Ferrannini E.
Effect of levothyroxine on cardiac function and structure in subclinical
hypothyroidism: A double blind, placebo-controlled study. The Journal of clinical
endocrinology and metabolism. 2001;86:1110-1115
Bell GM, Todd WT, Forfar JC, Martyn C, Wathen CG, Gow S, Riemersma R, Toft
AD. End-organ responses to thyroxine therapy in subclinical hypothyroidism. Clinical
endocrinology. 1985;22:83-89
Kim SK, Kim SH, Park KS, Park SW, Cho YW. Regression of the increased common
carotid artery-intima media thickness in subclinical hypothyroidism after thyroid
hormone replacement. Endocrine journal. 2009;56:753-758
Nagasaki T, Inaba M, Henmi Y, Kumeda Y, Ueda M, Tahara H, Sugiguchi S,
Fujiwara S, Emoto M, Ishimura E, Onoda N, Ishikawa T, Nishizawa Y. Decrease in
carotid intima-media thickness in hypothyroid patients after normalization of thyroid
function. Clinical endocrinology. 2003;59:607-612
Abdulrahman RM, Delgado V, Ng AC, Ewe SH, Bertini M, Holman ER, Hovens GC,
Pereira AM, Romijn JA, Bax JJ, Smit JW. Abnormal cardiac contractility in longterm exogenous subclinical hyperthyroid patients as demonstrated by twodimensional echocardiography speckle tracking imaging. European journal of
endocrinology / European Federation of Endocrine Societies. 2010;163:435-441
18.
19.
20.
Galderisi M, Henein MY, D'Hooge J, Sicari R, Badano LP, Zamorano JL, Roelandt
JR. Recommendations of the european association of echocardiography: How to use
echo-doppler in clinical trials: Different modalities for different purposes. European
journal of echocardiography : the journal of the Working Group on
Echocardiography of the European Society of Cardiology. 2011;12:339-353
Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA,
Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ.
Subclinical thyroid disease: Scientific review and guidelines for diagnosis and
management. Jama. 2004;291:228-238
Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S, Wemeau JL.
2013 eta guideline: Management of subclinical hypothyroidism. European thyroid
journal. 2013;2:215-228
Title: Adrenal hormones and the heart
References
1.
Taddei S, Virdis A, Mattei P, et al. Vasodilation to acetylcholine in primary and
secondary forms of human hypertension. Hypertension 1993;21(6 Pt 2):929-33.
2.
Fuller PJ, Young MJ. Mechanisms of mineralocorticoid action. Hypertension
2005;46(6):1227-35.
3.
Milliez P, Girerd X, Plouin PF, et al. Evidence for an increased rate of cardiovascular
events in patients with primary aldosteronism. J Am Coll Cardiol 2005;45(8):1243-8.
4.
Catena C, Colussi G, Nadalini E, et al. Cardiovascular outcomes in patients with
primary aldosteronism after treatment. Arch Intern Med 2008;168(1):80-5.
5.
Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and
mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study
Investigators. N Engl J Med 1999;341(10):709-17.
6.
Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in
patients with left ventricular dysfunction after myocardial infarction. N Engl J Med
2003;348(14):1309-21.
7.
Zannad F, McMurray JJ, Krum H, et al. Eplerenone in patients with systolic heart
failure and mild symptoms. N Engl J Med 2011;364(1):11-21.
8.
Pitt B, Anker SD, Bohm M, et al. Rationale and design of MinerAlocorticoid
Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of
finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes
and/or chronic kidney disease. Eur J Heart Fail 2015;17(2):224-32.
9.
Vaclavik J, Sedlak R, Plachy M, et al. Addition of spironolactone in patients with
resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled
trial. Hypertension 2011;57(6):1069-75.
10.
Deinum J, Riksen NP, Lenders JW. Pharmacological treatment of aldosterone excess.
Pharmacol Ther 2015.
11.
Traish AM, Kang HP, Saad F, et al. Dehydroepiandrosterone (DHEA)--a precursor
steroid or an active hormone in human physiology. J Sex Med 2011;8(11):2960-82; quiz
2983.
12.
Tivesten A, Vandenput L, Carlzon D, et al. Dehydroepiandrosterone and its sulfate
predict the 5-year risk of coronary heart disease events in elderly men. J Am Coll Cardiol
2014;64(17):1801-10.
13.
Jimenez MC, Sun Q, Schurks M, et al. Low dehydroepiandrosterone sulfate is
associated with increased risk of ischemic stroke among women. Stroke 2013;44(7):1784-9.
14.
Brotman DJ, Golden SH, Wittstein IS. The cardiovascular toll of stress. Lancet
2007;370(9592):1089-100.
15.
Pimenta E, Wolley M, Stowasser M. Adverse cardiovascular outcomes of
corticosteroid excess. Endocrinology 2012;153(11):5137-42.
16.
Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is
associated with subsequent cardiovascular disease. Ann Intern Med 2004;141(10):764-70.
17.
Clayton RN, Raskauskiene D, Reulen RC, et al. Mortality and morbidity in Cushing's
disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. J Clin
Endocrinol Metab 2011;96(3):632-42.
18.
Hare DL, Toukhsati SR, Johansson P, et al. Depression and cardiovascular disease: a
clinical review. Eur Heart J 2014;35(21):1365-72.
19.
Bruno RM, Ghiadoni L, Seravalle G, et al. Sympathetic regulation of vascular
function in health and disease. Front Physiol 2012;3:284.
20.
Bruno RM, Di Giulio A, Bernini G, et al. Device-based therapies for resistant
hypertension. Curr Pharm Des 2013;19(13):2401-8.
21.
Wittstein IS, Thiemann DR, Lima JA, et al. Neurohumoral features of myocardial
stunning due to sudden emotional stress. N Engl J Med 2005;352(6):539-48.
22.
Galetta F, Franzoni F, Bernini G, et al. Cardiovascular complications in patients with
pheochromocytoma: a mini-review. Biomed Pharmacother 2010;64(7):505-9.